KRN7000 applied to Multiple myeloma research

A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma

 

Meet Funakoshi Company

Please visit our booth at:

NIH Research Festival
October 11-12, 2012
Booth# 566